Literature DB >> 21462284

Reversed sequence enhances antimicrobial activity of a synthetic peptide.

Ramamourthy Gopal1, Young Jin Kim, Chang Ho Seo, Kyung-Soo Hahm, Yoonkyung Park.   

Abstract

A class of cationic antimicrobial peptides involved in host defense consists of sequences rich in Lys and Trp. Small peptides, (WK)(3) and (KW)(3) , were designed by the combination of alternating Lys (K) and Trp (W) amino acids, and then their antimicrobial and hemolytic activities were determined. It was noticed that the reversed sequence of (KW)(3) showed more activity against all strains than did (WK)(3) . The non-hemolytic behavior of (WK)(3) is identical to that of the reversed analog of (KW)(3) . CD spectra revealed that these peptides had an unfolded structure in buffer and EYPC:CH (10:1, w/w), but adopted folded conformation in the presence of EYPE:EYPG (7:3, w/w). The reversed-(KW)(3) peptide caused a higher extent of calcein release from EYPE:EYPG (7:3, w/w), though the activity was higher than that of the (WK)(3) . The interaction of the peptides with model lipid vesicles was examined using Trp fluorescence. The reversed-(KW)(3) showed higher interaction with EYPE:EYPG (7:3, w/w) membrane than did (WK)(3) . Both the peptides show less affinities while binding to EYPC:CH (10:1, w/w). This clearly indicated that the reversal of sequence factors is relevant to increased antimicrobial activity and lipid membrane permeability.
Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21462284     DOI: 10.1002/psc.1369

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  8 in total

1.  Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds.

Authors:  Johana Gómez; Diego Sierra; Claudia Ojeda; Sugina Thavalingam; Reece Miller; Fanny Guzmán; Nils Metzler-Nolte
Journal:  J Biol Inorg Chem       Date:  2021-07-22       Impact factor: 3.358

2.  Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides.

Authors:  Ramamourthy Gopal; Chang Ho Seo; Peter I Song; Yoonkyung Park
Journal:  Amino Acids       Date:  2012-08-23       Impact factor: 3.520

3.  Applications of circular dichroism for structural analysis of gelatin and antimicrobial peptides.

Authors:  Ramamourthy Gopal; Jin Soon Park; Chang Ho Seo; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2012-03-08       Impact factor: 6.208

4.  Retro analog concept: comparative study on physico-chemical and biological properties of selected antimicrobial peptides.

Authors:  Damian Neubauer; Maciej Jaśkiewicz; Dorian Migoń; Marta Bauer; Karol Sikora; Emilia Sikorska; Elżbieta Kamysz; Wojciech Kamysz
Journal:  Amino Acids       Date:  2017-07-29       Impact factor: 3.520

5.  Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups.

Authors:  H Bauke Albada; Alina-Iulia Chiriac; Michaela Wenzel; Maya Penkova; Julia E Bandow; Hans-Georg Sahl; Nils Metzler-Nolte
Journal:  Beilstein J Org Chem       Date:  2012-10-15       Impact factor: 2.883

6.  Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum.

Authors:  Ramamourthy Gopal; Hyungjong Na; Chang Ho Seo; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2012-11-15       Impact factor: 5.923

7.  Derivatives of the antimicrobial peptide BP100 for expression in plant systems.

Authors:  Esther Badosa; Gemma Moiset; Laura Montesinos; Montserrat Talleda; Eduard Bardají; Lidia Feliu; Marta Planas; Emilio Montesinos
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 8.  Antibiotic Potential and Biophysical Characterization of Amphipathic β-Stranded [XZ]n Peptides With Alternating Cationic and Hydrophobic Residues.

Authors:  Erik Strandberg; Parvesh Wadhwani; Anne S Ulrich
Journal:  Front Med Technol       Date:  2021-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.